Pulmonary Artery Catheter Market Report and Forecast 2025-2034

The global pulmonary artery catheter market was valued at USD 1.22 billion in 2024, driven by the rising population, increasing number of smokers, rising prevalence of diseases caused by a sedentary lifestyle across the globe. The market is anticipated to grow at a CAGR of 4.60% during the forecast period of 2025-2034 to achieve a value of USD 1.91 billion by 2034.

Pulmonary Artery Catheter Market Overview

A pulmonary artery catheter is a specialised medical device used to monitor heart and lung function in critically ill patients. Inserted through a large vein into the pulmonary artery, it measures key parameters such as cardiac output, pulmonary artery pressure, and oxygen levels. This real-time haemodynamic data aids in diagnosing and managing conditions like heart failure, sepsis, and shock. Commonly used in intensive care units and during complex surgeries, pulmonary artery catheters help optimise fluid management, guide treatment decisions, and improve patient outcomes in high-risk cardiovascular and respiratory conditions.

Pulmonary Artery Catheter Market Growth Drivers

Rising Merger and Acquisition Activities to Boost Market Value

The increasing demand for advanced patient monitoring technologies and the expansion of smart connected care solutions are significant drivers for the global market. For instance, in June 2024, BD (Becton, Dickinson and Company) announced its acquisition of Edwards Lifesciences' Critical Care product group for USD 4.2 billion. Critical Care, a leader in hemodynamic monitoring, provides real-time cardiovascular insights to critically ill patients, aiding improved patient outcomes. This acquisition enhances BD’s portfolio and fosters innovation in patient monitoring, especially in intensive care settings. As the demand for more sophisticated, interoperable monitoring systems grows, this strategic move is expected to positively influence market growth by offering cutting-edge solutions and unlocking new value creation, driving both technological development and market expansion in the forecast period.

Technological Advancements to Promote Pulmonary Artery Catheter Market Value

The technological advancements in heart failure management and the rising need for effective treatments for severe cardiovascular conditions are driving the market significantly. For instance, in July 2024, Edwards Lifesciences announced several strategic investments, including the acquisition of JenaValve Technology and Endotronix. JenaValve’s transcatheter treatment for aortic regurgitation (AR) and Endotronix’s Cordella implantable pulmonary artery pressure sensor will address critical unmet needs in heart failure and structural heart diseases. These acquisitions will strengthen Edwards’ portfolio and lead to the development of life-saving technologies. In the forecast period, these innovations are poised to expand market opportunities, particularly in areas related to pulmonary artery monitoring, driving both market value and long-term growth.

Pulmonary Artery Catheter Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Technological Advancements Driving the Market Growth

Technological innovations, such as wireless pulmonary artery catheters, are enhancing the precision and ease of heart failure management. These advanced devices provide real-time, continuous monitoring of pulmonary artery pressures, offering critical insights into a patient's cardiovascular status. Wireless technology improves patient comfort, eliminates the need for frequent hospital visits, and supports better outcomes. These advancements are expected to increase demand for pulmonary artery catheters in hospital settings, particularly for monitoring patients with heart failure, leading to significant growth in the market during the forecast period.

Increasing Prevalence of Cardiovascular Diseases Driving the Pulmonary Artery Catheter Market Growth

The global rise in cardiovascular diseases, including heart failure and pulmonary hypertension, is fueling demand for advanced monitoring solutions like pulmonary artery catheters. As healthcare providers increasingly prioritise real-time monitoring for critical care patients, the adoption of these devices is expanding. Pulmonary artery catheters enable physicians to manage complex conditions by providing accurate measurements of pulmonary pressures and cardiac output. This growing prevalence is expected to drive market development, especially in emerging economies where access to advanced healthcare technologies is improving, thereby increasing patient outcomes and market demand.

Rising Demand for Minimally Invasive Procedures Promoting Pulmonary Artery Catheter Market Size

The shift towards minimally invasive medical procedures is a key factor in the growing adoption of pulmonary artery catheters. These catheters allow physicians to monitor patients without the need for complex surgeries, improving patient comfort and recovery times. As healthcare systems focus on reducing hospital stays and complications, the preference for less invasive options, including these catheters, is increasing. This trend is likely to lead to an expanded market, with an emphasis on devices that offer high precision and ease of use, driving substantial market growth over the next few years.

Government And Healthcare Initiatives Driving the Pulmonary Artery Catheter Market Value

Government support for healthcare infrastructure, especially in developing nations, is accelerating the adoption of advanced medical devices, including pulmonary artery catheters. Healthcare reforms and increased funding for cardiovascular care are expanding access to life-saving treatments and monitoring technologies. These initiatives are fostering growth in the pulmonary artery catheter market by enabling widespread use in hospitals and specialised cardiovascular care centres. Additionally, government-backed research into cardiovascular diseases and medical technologies is expected to contribute to market value expansion, promoting further innovation and accessibility of pulmonary artery catheter systems worldwide.

Pulmonary Artery Catheter Market Segmentation

Pulmonary Artery Catheter Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

• Four-Lumen Catheter
• Five-Lumen Catheter
• Six-Lumen Catheter
• Others

Market Breakup by Application

• Cardiovascular
• Intravenous
• Neurovascular
• Urology
• Specialty

Market Breakup by End User

• Hospital
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Pulmonary Artery Catheter Market Share

Four-Lumen Catheter to Leading the Market Segmentation by Type

The four-lumen catheter is poised to hold the largest market share due to its versatility and efficiency in measuring various haemodynamic parameters simultaneously. It allows accurate pulmonary pressure measurement, cardiac output monitoring, and blood oxygen levels, essential for critical care and cardiology. Market drivers include the rising incidence of cardiovascular diseases, demand for minimally invasive diagnostic procedures, and technological advancements in catheter design. As healthcare systems continue to focus on improving patient outcomes and monitoring capabilities, the four-lumen segment is projected to lead the market, driving consistent growth in the forecast period.

Cardiovascular Applications to Dominate the Pulmonary Artery Catheter Market Segmentation by Application

Cardiovascular applications are set to dominate the pulmonary artery catheter market due to the increasing prevalence of heart diseases such as heart failure, hypertension, and arrhythmias. Pulmonary artery catheters are critical for assessing cardiovascular function and helping healthcare providers make informed decisions for patient management. As the global cardiovascular disease burden grows, the demand for accurate, real-time monitoring solutions also increases. This trend, coupled with advancements in catheter technology, positions the cardiovascular application segment as the largest contributor to market growth in the coming years, driving increased adoption.

Hospitals to Lead the Pulmonary Artery Catheter Market by End User

Hospitals are the leading end-user segment driven by their need for advanced diagnostic and monitoring tools in critical care units, particularly for high-risk patients. Hospitals represent the largest patient base, including those suffering from cardiac and pulmonary conditions, where precise monitoring is essential for optimal management. The growth of intensive care units (ICUs) and the increasing number of cardiovascular surgeries are propelling demand for these devices. As hospitals focus on enhancing patient care and recovery, this segment is expected to drive continued market expansion in the forecast period.

Pulmonary Artery Catheter Market Analysis by Region

North America is expected to hold the largest market share, driven by its well-established healthcare infrastructure, high healthcare expenditure, and advanced medical technology adoption. The region’s strong emphasis on critical care and diagnostic advancements, coupled with the growing prevalence of cardiovascular diseases, is further propelling the demand for pulmonary artery catheters. Europe follows closely, with a well-developed healthcare system and increased focus on improving patient outcomes in intensive care units. The Asia Pacific region shows significant growth potential due to rising healthcare investments, improving medical infrastructure, and increasing awareness of advanced diagnostic procedures. Latin America and the Middle East & Africa are anticipated to see moderate growth due to regional healthcare advancements and increasing healthcare accessibility.

Leading Players in the Pulmonary Artery Catheter Market

The key features of the market report comprise patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Medtronic plc

Headquartered in Dublin, Ireland, Medtronic was founded in 1949 and is a global leader in medical technology. Its portfolio includes a wide range of solutions for various medical conditions, including cardiovascular, diabetes, and neurological disorders. In the pulmonary artery catheter market, Medtronic offers advanced monitoring systems designed to assess heart function and pulmonary pressure, providing critical data for managing patients with heart failure or acute conditions. The company’s commitment to innovation drives its development of high-performance products in this sector, improving patient outcomes globally.

Boston Scientific Corporation

Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific is renowned for its medical devices and innovations across several therapeutic areas, including cardiovascular and endoscopy. The company’s pulmonary artery catheter offerings focus on advanced diagnostic and monitoring solutions for heart and lung conditions. Boston Scientific's devices are critical in intensive care and critical care units, providing continuous monitoring to manage pulmonary artery pressures, improve treatment decisions, and enhance patient care. With a strong emphasis on minimally invasive techniques, it remains a key player in the global healthcare market.

Teleflex Incorporated

Established in 1943 and headquartered in Wayne, Pennsylvania, Teleflex is a leading global provider of medical devices, focusing on respiratory, urology, anaesthesia, and cardiovascular solutions. In the pulmonary artery catheter market, Teleflex provides a range of innovative diagnostic and monitoring tools, particularly for critical care settings. These devices help clinicians monitor cardiac output, pulmonary pressure, and other vital parameters, enabling better management of patients with severe heart and lung conditions. Teleflex’s commitment to enhancing patient care through advanced technology supports its growth in this important healthcare market.

Edwards Lifesciences Corporation

Edwards Lifesciences, founded in 1958 and headquartered in Irvine, California, is a leader in heart valve therapies and haemodynamic monitoring. The company’s portfolio includes products for the diagnosis and management of cardiovascular diseases. In the pulmonary artery catheter market, Edwards Lifesciences is known for its advanced haemodynamic monitoring systems, offering real-time data on heart and lung performance. These systems assist healthcare professionals in managing patients with heart failure, sepsis, and other severe cardiovascular conditions. Edwards' focus on innovation and precision continues to drive its success in the pulmonary artery catheter market.

Other key players in the market include Convatec Inc., Hollister Incorporated, ICU Medical, Inc., Argon Medical Devices, Inc., Cardinal Health, Inc., and Getinge AB.

Key Questions Answered in the Global Pulmonary Artery Catheter Market

• What was the global pulmonary artery catheter market value in 2024?
• What is the pulmonary artery catheter market forecast outlook for 2025-2034?
• What is market segmentation based on type?
• What is market segmentation based on application?
• What is market segmentation based on end users?
• What are the major factors aiding the pulmonary artery catheter market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major pulmonary artery catheter market trends?
• Which type will lead the market segment?
• Which application will lead the market segment?
• Which end user will lead the market segment?
• Who are the key players involved in the pulmonary artery catheter market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.